Search Within

Michael Morris

Formats
  1. Meeting Abstract (275)
  2. Journal Article (268)
  3. Review (20)
  4. Book Section (6)
  5. Editorial (6)
  6. Correspondence (4)
  7. Guidelines (3)
  8. Miscellaneous (2)
  9. Conference Paper (1)
  10. Research Letter (1)
Groups
  1. Department of Medicine (586)
  2. Genitourinary Oncology Service (586)
  3. Solid Tumor Oncology Division (586)
  4. Radiology, Department of (164)
  5. GSK Faculty (161)
  6. Molecular Imaging and Therapy Service (141)

More Groups

People
  1. Howard Scher (217)
  2. Steven Larson (93)
  3. Susan Slovin (90)
  4. Dana Rathkopf (79)
  5. Daniel Danila (54)
  6. Glenn Heller (54)

More People

Years
  1. 2025 (27)
  2. 2024 (50)
  3. 2023 (40)
  4. 2022 (50)
  5. 2021 (42)
  6. 2020 (35)

More Years

Publications
  1. Journal of Clinical Oncology (240)
  2. Journal of Nuclear Medicine (44)
  3. Clinical Cancer Research (33)
  4. Annals of Oncology (30)
  5. Cancer (18)
  6. European Urology (18)

More Publications

Publishers
  1. American Society of Clinical Oncology (250)
  2. Society of Nuclear Medicine (44)
  3. American Association for Cancer Research (43)
  4. Oxford University Press (41)
  5. Elsevier Science, Inc. (40)
  6. Elsevier Inc. (27)

More Publishers

Results (586)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Acupuncture for nocturia in survivors of prostate cancer: The NOCTURNAL randomized clinical trial
    Research Letter

    Liou, K. T.; Carlsson, S.; Ajay, D.; Sandhu, J. S.; Li, Y.; Li, Q. S.; Cheung, F.; Chong, K.; Booher, A.; Han, K.; more...
    JAMA Oncology (2025)

    Fulltext@MSK | Save
  • Impact of concomitant hormone therapy on the diagnostic performance of (18)F-piflufolastat PET/CT in prostate cancer patients: A sub-group analysis of OSPREY cohort B
    Journal Article

    Saperstein, L.; Rowe, S. P.; Gorin, M. A.; Pienta, K. J.; Siegel, B. A.; Morris, M. J.; Baskaran, S.; Stambler, N.; DiPippo, V. A.; Denes, B. S.
    Prostate (2025)

    Fulltext@MSK | Save
  • Health-related quality of life, pain, and symptomatic skeletal events with [(177)Lu]Lu-PSMA-617 in patients with progressive metastatic castration-resistant prostate cancer (PSMAfore): An open-label, randomised, phase 3 trial
    Journal Article

    Fizazi, K.; Morris, M. J.; Shore, N.; Chi, K. N.; Crosby, M.; de Bono, J. S.; Herrmann, K.; Roubaud, G.; Nagarajah, J.; Fleming, M.; more...
    Lancet Oncology (2025)

    Fulltext@MSK | Save
  • Symptomatic prostate-specific membrane antigen PET–positive radionecrosis after multimodality brain metastasis–directed treatment including [(177)Lu]Lu-PSMA-617
    Journal Article

    Imber, B. S.; Yu, K. K. H.; Abida, W.; Pike, L. R. G.; Grkovski, M.; Kaley, T. J.; Morris, M. J.; Bodei, L.; Nosov, A.; Dunphy, M. P. S.; more...
    Journal of Nuclear Medicine (2025)

    Fulltext@MSK | Save
  • Patient-reported experience with an immunotherapy telehealth platform
    Meeting Abstract

    Daly, R. M.; Malling, C.; Dagostino, A.; Bange, E. M.; Preeshagul, I. R.; Aggen, D. H.; Carlo, M.; Chen, M. F.; Eng, J.; Ng, K. K.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Pilot study of an enhanced telehealth program for patients with prostate cancer
    Meeting Abstract

    Bange, E. M.; Reiner, A. S.; Liebertz, C.; Chimonas, S.; Daly, R. M.; Malling, C.; Lei, S.; Campbell, R.; Stevanovic, K.; Holland, J. C.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Implementation of universal germline genetic testing into standard of care for patients with prostate cancer: The time is now
    Journal Article

    Shore, N.; Nielsen, S. M.; Esplin, E. D.; Antonarakis, E. S.; Barata, P. C.; Beer, T. M.; Beltran, H.; Bryce, A.; Cookson, M. S.; Crawford, E. D.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • Quality of informed consent via telemedicine compared with in-person for clinical cancer research
    Journal Article

    Sternschuss, M.; Lattanzi, M.; Vertosick, E.; Austria, M.; Martin, S.; Regazzi, A.; Buckely, M. T.; Lengfellner, J.; Riely, G. J.; Solit, D. B.; more...
    JCO Oncology Practice (2025)

    Fulltext@MSK | Save
  • BCL2 drives castration resistance in castration-sensitive prostate cancer by orchestrating reciprocal crosstalk between oncogenic pathways
    Journal Article

    Hirani, R.; Nandakumar, S.; Zaman, N.; Prabhakaraalva, P.; King, S. A.; Kalidindi, T. M.; Ghale, R.; Rajanala, S. H.; Fidele, D. C.; De Stanchina, E.; more...
    Cell Reports (2025)

    Fulltext@MSK | Save
  • Prognostic and predictive analyses of circulating plasma biomarkers in men with metastatic castration resistant prostate cancer treated with docetaxel/prednisone with or without bevacizumab
    Journal Article

    Nixon, A. B.; Liu, Y. M.; Yang, Q.; Luo, B.; Starr, M. D.; Brady, J. C.; Kelly, W. K.; Beltran, H.; Morris, M. J.; George, D. J.; more...
    Prostate Cancer and Prostatic Diseases (2025)

    Fulltext@MSK | Save